ZTS
Zoetis Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -17.2% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 944.24K | $65.94M | n/a | n/a |
| Q2 2026 | 175 | +5 | 282.45M | $20.33B | +9 | −3 |
| Q1 2026 | 172 | -5 | 287.89M | $34.03B | +1 | −7 |
| Q4 2025 | 176 | -2 | 318.69M | $40.10B | +3 | −4 |
| Q3 2025 | 25 | -1 | 154.48M | $22.59B | n/a | −2 |
| Q2 2025 | 24 | +2 | 132.57M | $20.67B | +2 | n/a |
| Q1 2025 | 19 | 0 | 50.59M | $8.32B | n/a | n/a |
| Q4 2024 | 19 | +1 | 54.43M | $8.86B | +1 | n/a |
| Q3 2024 | 17 | 0 | 31.69M | $6.18B | +1 | −1 |
| Q2 2024 | 17 | n/a | 38.28M | $6.63B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passief) | 10.43M | +1.8% | $2.03B | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Capital World Investors ✦ | 6.68M | -1.5% | $1.31B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 3 | Norges Bank ✦ (passief) | 4.97M | -0.8% | $970.34M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 4.13M | -13.9% | $806.14M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 3.90M | -58.7% | $761.84M | 0.1% | ▼ Trim | 2 | SEC ↗ ×7 |
| 6 | Marshall Wace ✦ | 812.73K | -2.8% | $158.79M | 0.2% | ▼ Trim | 2 | SEC ↗ ×3 |
| 7 | AQR Capital Management ✦ | 262.93K | +169.7% | $51.22M | 0.1% | ▲ Add | 2 | SEC ↗ ×4 |
| 8 | Adage Capital Partners ✦ | 217.27K | +96.8% | $42.45M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 112.65K | -71.7% | $22.01M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 68.01K | -2.9% | $13.29M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 11 | Bridgewater Associates ✦ | 51.79K | -37.4% | $10.12M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 19.55K | Nieuw | $3.82M | 0.0% | New | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 18.87K | -86.4% | $3.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | GAMCO Investors ✦ | 13.71K | -6.3% | $2.68M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 3.97K | +56.0% | $775,854 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 1.95K | -51.5% | $380,661 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Dodge & Cox ✦ | 1.70K | 0.0% | $332,146 | 0.0% | Held | 2 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Arrowstreet Capital | $3.82M | 0.0% |
Verlaten
| Citadel Advisors | $45.30M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,596 houders, 404.54M aandelen, $46.32B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.